Next Article in Journal
The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa
Next Article in Special Issue
Entry Efficiency, Protease Dependence, and Antibody-Mediated Neutralization of SARS-CoV-2 Sublineages KP.3.1.1 and XEC
Previous Article in Journal
Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer
Previous Article in Special Issue
Immune Imprinting, Non-Durable Hybrid Immunity, and Hybrid Immune Damping Following SARS-CoV-2 Primary Vaccination with BNT162b2 and Boosting with mRNA-1273
 
 
Article

Article Versions Notes

Vaccines 2025, 13(3), 315; https://doi.org/10.3390/vaccines13030315
Action Date Notes Link
article xml file uploaded 14 March 2025 14:34 CET Original file -
article xml uploaded. 14 March 2025 14:34 CET Update -
article pdf uploaded. 14 March 2025 14:34 CET Version of Record -
article html file updated 14 March 2025 14:36 CET Original file -
article xml file uploaded 14 March 2025 15:53 CET Update -
article xml uploaded. 14 March 2025 15:53 CET Update https://www.mdpi.com/2076-393X/13/3/315/xml
article pdf uploaded. 14 March 2025 15:53 CET Updated version of record https://www.mdpi.com/2076-393X/13/3/315/pdf
article html file updated 14 March 2025 15:55 CET Update https://www.mdpi.com/2076-393X/13/3/315/html
Back to TopTop